Columbus Macro’s Sabra Healthcare REIT SBRA Stock Holding History

Columbus Macro’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-330,755	Closed	-$5.73M	–	212
2024 Q4	$5.73M	Buy	+330,755	New	+$6.04M	0.79%	47

Other funds holding SBRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Columbus Macro's SBRA Position: Q1 2025 in Review

Columbus Macro sold out of Sabra Healthcare REIT (SBRA) in Q1 2025, closing a stake of 330,755 shares — an estimated $5.73M sold.

Columbus Macro first reported a position in SBRA in Q4 2024 and held it in 1 quarter. The position peaked at $5.73M in Q4 2024. 403 funds tracked by Wall St. Rank hold SBRA as of Q1 2025.

Columbus Macro reported no remaining Sabra Healthcare REIT position as of Q1 2025 after selling out during the quarter.
Columbus Macro sold 330,755 Sabra Healthcare REIT shares in Q1 2025, an estimated $5.73M.
Columbus Macro first reported a position in Sabra Healthcare REIT in Q4 2024 and held it in 1 quarter.
Columbus Macro's Sabra Healthcare REIT position peaked at $5.73M in Q4 2024.
403 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2025.

Based on Columbus Macro's 13F filing for Q1 2025, filed 17 Apr 2025.